Galafold (migalastat) 123MG caps

Ended Awarded

Contract number
36C24925F0099
Awardee
Awarding agency
Obligated
$65,674

Award facts

Contract value 100% obligated
$65,673.63 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Philadelphia, PA 19104, USA

Award details come from SAM.gov/FPDS.

About this award

This federal contract award is for the delivery of the drug Galafold (migalastat) 123mg capsules to the Department of Veterans Affairs (VA). The prime contractor is Amicus Therapeutics US, LLC, a subsidiary of the parent company Amicus Therapeutics, Inc. The contract has a ceiling value of $65,673.63 and is a firm fixed price delivery order with a period of performance through February 8, 2025.

The contract was awarded by the VA's Veterans Integrated Service Network 9 (VISN 9) and has no set-aside designation. Amicus Therapeutics US, LLC holds a Federal Supply Schedule (FSS) contract with the VA for pharmaceuticals and drugs, which serves as the vehicle for this specific order. The FSS contract has a ceiling value of $13,024,630 and a period of performance through August 31, 2029. This contract award supports the VA's mission to provide specialized healthcare services and medications, including treatments for rare diseases such as Fabry disease, to veterans across the country.

Quick answers

Who was awarded contract 36C24925F0099?

36C24925F0099 was awarded to Amicus Therapeutics US, LLC by Veterans Integrated Service Network 9 (Veterans Health Administration) on January 8, 2025.

How much is contract 36C24925F0099 worth?

The government has obligated $65,674 on 36C24925F0099.

Is contract 36C24925F0099 an order under another contract?

Yes. 36C24925F0099 is a delivery order under 36F79724D0185, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C24925F0099 competed?

The extent of competition for 36C24925F0099 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award